Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15